1. Home
  2. BMHL vs PMVP Comparison

BMHL vs PMVP Comparison

Compare BMHL & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BMHL

Bluemount Holdings Limited Class B Ordinary Shares

N/A

Current Price

$3.33

Market Cap

93.9M

Sector

N/A

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.31

Market Cap

79.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMHL
PMVP
Founded
2016
2013
Country
Hong Kong
United States
Employees
9
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.9M
79.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BMHL
PMVP
Price
$3.33
$1.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.6K
894.8K
Earning Date
08-14-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$66.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.72
$0.82
52 Week High
$4.48
$1.88

Technical Indicators

Market Signals
Indicator
BMHL
PMVP
Relative Strength Index (RSI) 46.53 41.81
Support Level $3.32 $1.26
Resistance Level $3.89 $1.50
Average True Range (ATR) 0.16 0.06
MACD -0.01 -0.04
Stochastic Oscillator 50.00 2.56

Price Performance

Historical Comparison
BMHL
PMVP

About BMHL Bluemount Holdings Limited Class B Ordinary Shares

Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: